Concomitant use of SSRIs, NSAIDsAspirin and gastroprotective drugs among residents of long-term care facilities: A medical record review

Clinical Drug Investigation

Volumn 31, Issue 5, 2011, Pages 337-344

  Bell, J Simon ^a   Taipale, Heidi T ^a   Soini, Helena ^b   Pitkälä, Kaisu H ^c,d  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b City of Helsinki   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aspirin; Drug interactions; Elderly; Gastrointestinal haemorrhage; Nonsteroidal anti inflammatories; Proton pump inhibitors; Serotonin uptake inhibitors; therapeutic use

Indexed keywords

ACETYLSALICYLIC ACID; CITALOPRAM; CLOPIDOGREL; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; DIPYRIDAMOLE; ETODOLAC; FLUOXETINE; FLUVOXAMINE; GASTROINTESTINAL AGENT; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PIROXICAM; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOLFENAMIC ACID; WARFARIN;

AGED; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIAGNOSTIC TEST; DRUG USE; FEMALE; FINLAND; HEALTH CARE FACILITY; HEART INFARCTION; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MORTALITY; MULTICENTER STUDY; NURSE; PREVALENCE; PRIORITY JOURNAL; RESIDENT; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; STROKE; UPPER GASTROINTESTINAL BLEEDING; WARD; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; GASTROINTESTINAL HEMORRHAGE; MEDICAL RECORD; STATISTICS;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; DRUG INTERACTIONS; FEMALE; FINLAND; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; LONG-TERM CARE; MALE; MEDICAL RECORDS; SEROTONIN UPTAKE INHIBITORS;

EID: 79953825776     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11588820-000000000-00000     Document Type: Review

References (49)

1. Hartikainen SA, Mantyselka P, Louhivuori-Laako K, et al. Concomitant use of analgesics and psychotropics in home-dwelling elderly people: Kuopio 75+ study. Br J Clin Pharmacol 2005; 60: 306-10 (Pubitemid 41224139)
2. Pitkala KH, Strandberg TE, Tilvis RS. Management of nonmalignant pain in home-dwelling older people: a po-pulation-based survey. J Am Geriatr Soc 2002; 50: 1861-5 (Pubitemid 35291732)
3. Won AB, Lapane KL, Vallow S, et al. Persistent nonmalignant pain and analgesic prescribing patterns in elderly nursing home residents. J Am Geriatr Soc 2004; 52: 867-74 (Pubitemid 38789056)
4. de Abajo FJ, Garcia-Rodriguez LS, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999; 319: 1106-9 (Pubitemid 29494721)
5. Dalton SO, Johansen C, Mellemkjaer L, et al. Use of selective serotonin reuptake inhibitors and risk of upper gas-trointestinal tract bleeding: a population based cohort study. Arch Intern Med 2003; 163: 59-64 (Pubitemid 36091601)
6. Yuan Y, Tsoi K, Hunt RH. Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding? Am J Med 2006; 119: 719-27 (Pubitemid 44291626)
7. Schoenfeld P, Kimmey MB, Scheiman J, et al. Review article: nonsteroidal anti-inflammatory drug-associated gastro-intestinal complications. Guidelines for prevention and treatment. Aliment Pharmacol Ther 1999; 13: 1273-85 (Pubitemid 29462302)
8. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective seroto-nin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2008; 27: 31-40 (Pubitemid 350212624)
9. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123: 241-9
10. Carson JL, Strom BL, Soper KA, et al. The association of nonsteroidal anti-inflammatory drugs with upper gastro-intestinal tract bleeding. Arch Intern Med 1987; 147: 85-8 (Pubitemid 17010766)
11. de Abajo FJ, Garcia-Rodriguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry 2008; 65: 795-803 (Pubitemid 351957705)
12. Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians. Drugs Aging 2008; 25: 777-93
13. Laine L, Connors L, Griffin MR, et al. Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines. Aliment Pharmacol Ther 2009; 30: 767-74
14. Dries AM, Richardson P, Cavazos J, et al. Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-inflammatory drug users. Aliment Phar-macol Ther 2009; 30: 652-61
15. Gadzhanova SV, Roughead EE, Mackson JM. Initiation and duration of proton pump inhibitors in the Australian veteran population. Intern Med J. Epub 2010 May 11
16. Gray SL, LaCroix AZ, Larson J, et al. Proton pump inhibitor use, hip fracture, and change in bone mineral den-sity in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med 2010; 170: 765-71
17. Linsky A, Gupta K, Lawler EV, et al. Proton pump inhibitors and risk for recurrent Clostridium difficile infec-tion. Arch Intern Med 2010; 170: 772-8
18. Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 2007; 167: 950-5 (Pubitemid 46762758)
19. Bell JS, Strandberg TE, Teramura-Gronblad M, et al. Use of proton-pump inhibitors and mortality among institutionalized older people. Arch Intern Med 2010; 170: 1604-5
20. Karvonen A-L, Hakala M, Helin-Salmivaara A, et al. Thesafe use ofnon-steroidal anti-inflammatory drugs. Finnish Med-ical Society Duodecim, Finnish Society of Gastroenterology & Finnish Rheumatology Society [online]. Available from URL: http://www.kaypahoito.fi/[Accessed 2010 Sep 12]
21. Moore RA, Derry S, McQuay HJ. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk. BMC Musculoskelet Disord 2007; 8: 73
22. Suominen MH, Sandelin E, Soini H, et al. How well do nurses recognize malnutrition in elderly patients? Eur J Clin Nutr 2009; 63: 292-6
23. Taipale HT, Bell JS, Soini H, et al. Sedative load and mortality among residents of long-term care facilities: a pro-spective cohort study. Drugs Aging 2009; 26: 871-81
24. Bell JS, Taipale HT, Soini H, et al. Sedative load among long term care facility residents with and without dementia. Clin Drug Investig 2010; 30: 63-70
25. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and evaluation. J Chronic Dis 1987; 40: 373-83 (Pubitemid 17055592)
26. Buntinx F, Niclaes L, Seutens C, et al. Evaluation of Charlson's comorbidity index in elderly living in nursing homes. J Clin Epidemiol 2002; 55: 1144-7 (Pubitemid 36043992)
27. Guigoz Y, Lauque S, Vellas BJ. Identifying the elderly at risk for malnutrition: the Mini Nutritional Assessment. Clin Geriatr Med 2002; 18: 737-57 (Pubitemid 35239179)
28. Vandraas KF, Spigset O, Mahic M, et al. Non-steroidal anti-inflammatory drugs: use and co-treatment with po-tentially interacting medications in the elderly. Eur J Clin Pharmacol 2010; 66: 823-9
29. Lindh JD, Holm L, Dahl ML, et al. Incidence andpredictors of severe bleeding during warfarin treatment. J Thromb Haemost 2008; 25: 151-9 (Pubitemid 351583663)
30. Hauta-Aho M, Tirkkonen T, Vahlberg T, et al. The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients. Ann Med 2009; 41: 619-28
31. Abraham NS, Hartman CH, Castillo D, et al. Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users. Am J Gastroenterol2008; 103: 323-32 (Pubitemid 351248716)
32. Helin-Salmivaara A, Huttunen T, Gronroos JM, et al. Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: a case-control study in the general population. Eur J Clin Pharmacol 2007; 63: 403-8 (Pubitemid 46399132)
33. Johnell K, Fastbom J. Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study. Clin Drug In-vestig 2008; 28: 687-95
34. Hartikainen SA, Mantyselka PT, Louhivuori-Laako KA, et al. Balancing pain and analgesic treatment in the home-dwelling elderly. Ann Pharmacother 2005; 39: 11-6 (Pubitemid 40052371)
35. Pokela N, Bell JS, Lihavainen K, et al. Analgesic use among community-dwelling people aged 75 years and older: a population-based interview study. Am J Geriatr Pharma-cother 2010; 8: 233-44
36. Lanas A, Garcia-Rodriguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with se-lective cyclo-oxygenase-2 inhibitors, traditional non-aspi-rin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 2006; 55: 1731-8 (Pubitemid 44893570)
37. Sorensen HT, Mellemkjaer L, Blot WJ, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000; 95: 2218-24
38. Taha AS, Angerson WJ, Knill-Jones RP, et al. Upper gastrointestinal haemorrhage associated with low-dose aspirin and anti-thrombotic drugs: a 6-year analysis and compar-ison with non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005; 22: 285-9 (Pubitemid 41207457)
39. Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000; 321: 1183-7
40. Snowdon J, Fleming R. Recognising depression in residential facilities: an Australian challenge. Int J Geriatr Psychiatry 2008; 23: 295-300 (Pubitemid 351404025)
41. Alexopoulos GS. Depression in the elderly. Lancet 2005; 365: 1961-70 (Pubitemid 40797508)
42. Alexopoulos GS, Katz IR, Reynolds CF, et al. The expert consensus guideline series: pharmacotherapy of depressive disorders in older patients. Postgrad Med 2001; Special Report (October): 1-86
43. Draper B, Berman K. Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly. Drugs Aging 2008; 25: 501-19 (Pubitemid 351812258)
44. Monte S, Macchia A, Romero M, et al. Antidepressants and cardiovascular outcomes in patients without known cardiovascular risk. Eur J Clin Pharmacol 2009; 65: 1131-8
45. Francetic I, Bilusic M, Macolic-Sarinic V, et al. Inadequate use of preventive strategies in patients receiving NSAIDs. Clin Drug Investig 2006; 25: 265-70
46. Lau HS, de Boer A, Beuning KS, et al. Validation of pharmacy records in drug exposure assessment. J Clin Epide-miol 1997; 50: 619-25 (Pubitemid 27270212)
47. National Agency for Medicines and Social Insurance Institution of Finland. Finnish Statistics on Medicines. 2003 [online]. Available from URL: http://www.nam.fi/medi cines/drug-consumption/finnish-statistics-on-medicines [Accessed 2010 Oct 18]
48. National Agency for Medicines and Social Insurance Institution of Finland. Finnish Statistics on Medicines. 2009 [online]. Available from URL: http://www.nam.fi/medi cines/drug-consumption/finnish-statistics-on-medicines [Accessed 2010 Oct 18]
49. Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer com-plications. Am J Gastroenterol 2009; 104: 728-38